FY2024 EPS Estimates for Trupanion Lifted by William Blair

Trupanion, Inc. (NASDAQ:TRUPFree Report) – Equities researchers at William Blair lifted their FY2024 earnings per share estimates for shares of Trupanion in a research note issued to investors on Wednesday, October 30th. William Blair analyst B. Vazquez now anticipates that the financial services provider will post earnings per share of ($0.13) for the year, up from their previous estimate of ($0.17). William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Trupanion’s current full-year earnings is ($0.34) per share. William Blair also issued estimates for Trupanion’s Q4 2024 earnings at $0.14 EPS, Q1 2025 earnings at ($0.03) EPS, Q1 2026 earnings at $0.01 EPS and Q2 2026 earnings at $0.00 EPS.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The company had revenue of $327.50 million during the quarter, compared to the consensus estimate of $321.79 million. During the same period last year, the firm earned ($0.10) earnings per share. The company’s revenue was up 14.6% on a year-over-year basis.

A number of other equities research analysts have also recently weighed in on TRUP. Bank of America lifted their price target on Trupanion from $47.00 to $56.00 and gave the company a “buy” rating in a report on Friday, September 20th. Piper Sandler raised their price objective on shares of Trupanion from $45.00 to $57.00 and gave the company a “neutral” rating in a research note on Thursday, October 31st. Northland Securities lifted their price target on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus lifted their target price on shares of Trupanion from $30.00 to $40.00 and gave the company a “hold” rating in a research note on Monday, September 23rd. Finally, Evercore ISI raised shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Four equities research analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $44.67.

View Our Latest Analysis on TRUP

Trupanion Stock Performance

Shares of NASDAQ TRUP opened at $50.05 on Monday. The company has a quick ratio of 1.63, a current ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm’s 50-day moving average price is $47.11 and its two-hundred day moving average price is $36.63. Trupanion has a 52-week low of $19.69 and a 52-week high of $57.90. The stock has a market capitalization of $2.11 billion, a P/E ratio of -156.41 and a beta of 1.69.

Insider Transactions at Trupanion

In related news, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total transaction of $29,040.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Trupanion news, CFO Fawwad Qureshi sold 624 shares of the stock in a transaction on Monday, August 26th. The shares were sold at an average price of $46.54, for a total value of $29,040.96. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Margaret Tooth sold 7,500 shares of the firm’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $46.48, for a total transaction of $348,600.00. Following the sale, the chief executive officer now owns 99,984 shares of the company’s stock, valued at approximately $4,647,256.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 8,764 shares of company stock valued at $405,238 over the last quarter. Corporate insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Several hedge funds and other institutional investors have recently made changes to their positions in TRUP. Capstone Investment Advisors LLC acquired a new position in Trupanion during the 1st quarter worth approximately $269,000. GSA Capital Partners LLP boosted its stake in shares of Trupanion by 376.5% in the 1st quarter. GSA Capital Partners LLP now owns 80,046 shares of the financial services provider’s stock valued at $2,210,000 after purchasing an additional 63,247 shares during the last quarter. Texas Permanent School Fund Corp boosted its stake in Trupanion by 1.8% during the first quarter. Texas Permanent School Fund Corp now owns 31,269 shares of the financial services provider’s stock worth $863,000 after acquiring an additional 561 shares in the last quarter. SG Americas Securities LLC boosted its stake in Trupanion by 45.0% during the first quarter. SG Americas Securities LLC now owns 27,292 shares of the financial services provider’s stock worth $754,000 after acquiring an additional 8,473 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC bought a new position in Trupanion during the first quarter worth $473,000.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Further Reading

Earnings History and Estimates for Trupanion (NASDAQ:TRUP)

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.